A three-step method for the synthesis of methyl 5-(2,4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carboxylate 1, a key intermediate of fexuprazan, is reported in this paper. Using low-priced sodium p-tolylsulfinate as the starting material, compound 28 was obtained with a 96.8% yield in the first step by optimizing the experimental parameters with a Box–Behnken experimental design. Subsequently, isonitrile compound 29 was obtained by dehydration. Finally, impurities 31 and 32 in the last step of the reaction were identified and converted into target product 1 by a one-pot method, which significantly improves the utilization of atoms. Key intermediate 1 was obtained via a three-step process with a yield of 68–70% and purity that exceeded 99%. In addition, the mechanism of the cyclization reaction was proposed. This method has potential for industrial production because the raw materials are inexpensive, the procedure is simple, and a high yield is obtained.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: